Page last updated: 2024-08-21

methysergide and Heart Valve Diseases

methysergide has been researched along with Heart Valve Diseases in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (45.45)	18.7374
1990's	2 (18.18)	18.2507
2000's	4 (36.36)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baumann, MH; Hufeisen, SJ; McBride, A; Rauser, L; Roth, BL; Rothman, RB; Savage, JE	1
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH	1
Al-Masri, AH; Alizzi, AM; Challis, M; Dixit, AS; Hemli, JM; Murton, MM; Nicholson, MR; Yong, T	1
Altschuler, EL; Kast, RE	1
Grinberg, M; Halpern, A; Leite, CC; Rossi, EG; Sbano, JC	1
Baragan, J; Barrillon, A	1
Edwards, WD; Nicholson, WJ; Redfield, MM; Tajik, AJ	1
Misch, KA	1
Grahame-Smith, DG	1
Graham, JR; LeCompte, PR; Sadowsky, NL; Suby, HI	1

Reviews

2 review(s) available for methysergide and Heart Valve Diseases

Article	Year
Drug-induced fibrotic valvular heart disease. Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689 Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents	2009
Progress report: the carcinoid syndrome. Gut, 1970, Volume: 11, Issue:2 Topics: 5-Hydroxytryptophan; Antineoplastic Agents; Bradykinin; Diarrhea; Heart Valve Diseases; Humans; Hydroxyindoleacetic Acid; Kallikreins; Liver Neoplasms; Malignant Carcinoid Syndrome; Methyldopa; Methysergide; Neoplasm Metastasis; Phenoxybenzamine; Phenylalanine; Serotonin	1970

Article

Year

Drug-induced fibrotic valvular heart disease.

Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689

Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents

2009

Progress report: the carcinoid syndrome.

Gut, 1970, Volume: 11, Issue:2

Topics: 5-Hydroxytryptophan; Antineoplastic Agents; Bradykinin; Diarrhea; Heart Valve Diseases; Humans; Hydroxyindoleacetic Acid; Kallikreins; Liver Neoplasms; Malignant Carcinoid Syndrome; Methyldopa; Methysergide; Neoplasm Metastasis; Phenoxybenzamine; Phenylalanine; Serotonin

1970

Other Studies

9 other study(ies) available for methysergide and Heart Valve Diseases

Article	Year
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation, 2000, Dec-05, Volume: 102, Issue:23 Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergonovine; Norfenfluramine; Receptors, Serotonin; Serotonin Antagonists	2000
Methysergide-induced valvular heart disease: a report of 2 cases. The heart surgery forum, 2006, Volume: 9, Issue:5 Topics: Female; Fibrosis; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Methysergide; Middle Aged; Mitral Valve; Serotonin Antagonists	2006
Dopamine agonists and valvular heart disease. The New England journal of medicine, 2007, Apr-19, Volume: 356, Issue:16 Topics: Antipsychotic Agents; Cabergoline; Dopamine Agonists; Ergolines; Heart Valve Diseases; Humans; Methysergide; Pergolide; Receptor, Serotonin, 5-HT2B; Retroperitoneal Fibrosis; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists	2007
[The link between drug use and heart valve disease]. Arquivos brasileiros de cardiologia, 1998, Volume: 70, Issue:3 Topics: Appetite Depressants; Ergotamine; Heart Valve Diseases; Humans; Methysergide; Serotonin Antagonists	1998
Methysergide and tricuspid valve lesions [ letter]. Circulation, 1978, Volume: 58, Issue:3 Pt 1 Topics: Female; Heart Valve Diseases; Humans; Methysergide; Middle Aged; Tricuspid Valve	1978
Drugs for migraine. The Medical letter on drugs and therapeutics, 1976, Jun-18, Volume: 18, Issue:13 Topics: Caffeine; Clonidine; Drug Synergism; Ergotamine; Heart Valve Diseases; Humans; Methysergide; Migraine Disorders; Mitral Valve Insufficiency; Propranolol; Pulmonary Fibrosis	1976
Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations. Annals of internal medicine, 1992, Jul-01, Volume: 117, Issue:1 Topics: Adult; Echocardiography; Ergot Alkaloids; Ergotamine; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Methysergide; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Stenosis	1992
Development of heart valve lesions during methysergide therapy. British medical journal, 1974, May-18, Volume: 2, Issue:5915 Topics: Heart Valve Diseases; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Mitral Valve Stenosis; Tricuspid Valve Stenosis	1974
Fibrotic disorders associated with methysergide therapy for headache. The New England journal of medicine, 1966, Feb-17, Volume: 274, Issue:7 Topics: Adult; Aged; Aortic Diseases; Aortic Valve Insufficiency; Ergotamine; Female; Headache; Heart Valve Diseases; Humans; Hydronephrosis; Male; Methysergide; Middle Aged; Migraine Disorders; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Serotonin; Spondylitis, Ankylosing; Urography	1966